Annual Short Term Debt
$934.00 K
-$37.69 M-97.58%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual short term debt is $934.00 thousand, with the most recent change of -$37.69 million (-97.58%) on December 31, 2023.
- During the last 3 years, AVDL annual short term debt has risen by +$460.00 thousand (+97.05%).
- AVDL annual short term debt is now -97.58% below its all-time high of $38.63 million, reached on December 31, 2022.
Performance
AVDL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$725.00 K
-$141.00 K-16.28%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly short term debt is $725.00 thousand, with the most recent change of -$141.00 thousand (-16.28%) on September 30, 2024.
- Over the past year, AVDL quarterly short term debt has dropped by -$209.00 thousand (-22.38%).
- AVDL quarterly short term debt is now -98.38% below its all-time high of $44.63 million, reached on March 31, 2015.
Performance
AVDL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AVDL Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.6% | -22.4% |
| 3 y3 years | +97.0% | -96.7% |
| 5 y5 years | +781.1% | -96.7% |
AVDL Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.6% | +3.8% | -98.1% | at low |
| 5 y | 5-year | -97.6% | +97.0% | -98.1% | +53.0% |
| alltime | all time | -97.6% | +781.1% | -98.4% | +584.0% |
Avadel Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $725.00 K(-16.3%) |
| Jun 2024 | - | $866.00 K(-9.1%) |
| Mar 2024 | - | $953.00 K(+2.0%) |
| Dec 2023 | $934.00 K(-97.6%) | $934.00 K(-95.8%) |
| Sep 2023 | - | $22.10 M(+2.2%) |
| Jun 2023 | - | $21.63 M(+1.2%) |
| Mar 2023 | - | $21.39 M(-44.6%) |
| Dec 2022 | $38.63 M(+4192.0%) | $38.63 M(+41.4%) |
| Sep 2022 | - | $27.31 M(+0.5%) |
| Jun 2022 | - | $27.17 M(+0.3%) |
| Mar 2022 | - | $27.10 M(+2911.2%) |
| Dec 2021 | $900.00 K(+89.9%) | $900.00 K(+78.6%) |
| Sep 2021 | - | $504.00 K(+2.0%) |
| Jun 2021 | - | $494.00 K(+2.1%) |
| Mar 2021 | - | $484.00 K(+2.1%) |
| Dec 2020 | $474.00 K(-26.5%) | $474.00 K(-8.8%) |
| Sep 2020 | - | $520.00 K(-7.6%) |
| Jun 2020 | - | $563.00 K(-6.8%) |
| Mar 2020 | - | $604.00 K(-6.4%) |
| Dec 2019 | $645.00 K(+508.5%) | $645.00 K(-60.5%) |
| Sep 2019 | - | $1.63 M(+47.7%) |
| Jun 2019 | - | $1.10 M(+1.7%) |
| Mar 2019 | - | $1.09 M(+924.5%) |
| Dec 2018 | $106.00 K(-4.5%) | $106.00 K(-0.9%) |
| Sep 2018 | - | $107.00 K(-0.9%) |
| Jun 2018 | - | $108.00 K(-5.3%) |
| Mar 2018 | - | $114.00 K(+2.7%) |
| Dec 2017 | $111.00 K(-58.6%) | $111.00 K(-63.1%) |
| Sep 2017 | - | $301.00 K(+3.4%) |
| Jun 2017 | - | $291.00 K(+7.0%) |
| Mar 2017 | - | $272.00 K(+1.5%) |
| Dec 2016 | $268.00 K(-38.2%) | $268.00 K(-6.3%) |
| Sep 2016 | - | $286.00 K(+1.1%) |
| Jun 2016 | - | $283.00 K(-37.7%) |
| Mar 2016 | - | $454.00 K(+4.6%) |
| Dec 2015 | $434.00 K(-82.2%) | $434.00 K(-98.9%) |
| Jun 2015 | - | $37.80 M(-15.3%) |
| Mar 2015 | - | $44.63 M(+1729.2%) |
| Dec 2014 | $2.44 M(-87.3%) | $2.44 M(-91.3%) |
| Sep 2014 | - | $27.89 M(+53.9%) |
| Jun 2014 | - | $18.12 M(-0.0%) |
| Mar 2014 | - | $18.13 M(-5.6%) |
| Dec 2013 | $19.21 M(+460.4%) | $19.21 M(-6.0%) |
| Sep 2013 | - | $20.45 M(+197.4%) |
| Jun 2013 | - | $6.88 M(+106.6%) |
| Mar 2013 | - | $3.33 M(-2.9%) |
| Dec 2012 | $3.43 M | $3.43 M(+66.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $2.06 M(-5.7%) |
| Mar 2012 | - | $2.18 M(+2.7%) |
| Dec 2011 | $2.12 M(-10.6%) | $2.12 M(-4.6%) |
| Sep 2011 | - | $2.23 M(-6.3%) |
| Jun 2011 | - | $2.37 M(-7.2%) |
| Mar 2011 | - | $2.56 M(+7.6%) |
| Dec 2010 | $2.38 M(+165.5%) | $2.38 M(+8.4%) |
| Sep 2010 | - | $2.19 M(+186.9%) |
| Jun 2010 | - | $764.00 K(-8.8%) |
| Mar 2010 | - | $838.00 K(-6.4%) |
| Dec 2009 | $895.00 K(+18.9%) | $895.00 K(+19.5%) |
| Sep 2009 | - | $749.00 K(-0.7%) |
| Jun 2009 | - | $754.00 K(+10.9%) |
| Mar 2009 | - | $680.00 K(-9.7%) |
| Dec 2008 | $753.00 K(-23.2%) | $753.00 K(-6.5%) |
| Sep 2008 | - | $805.00 K(-13.5%) |
| Jun 2008 | - | $931.00 K(-6.1%) |
| Mar 2008 | - | $991.00 K(+1.1%) |
| Dec 2007 | $980.00 K(+133.3%) | $980.00 K(+225.6%) |
| Sep 2007 | - | $301.00 K(-10.4%) |
| Jun 2007 | - | $336.00 K(-10.9%) |
| Mar 2007 | - | $377.00 K(-10.2%) |
| Dec 2006 | $420.00 K(-49.3%) | $420.00 K(-47.2%) |
| Sep 2006 | - | $795.00 K(0.0%) |
| Jun 2006 | - | $795.00 K(+5.3%) |
| Mar 2006 | - | $755.00 K(-8.8%) |
| Dec 2005 | $828.00 K(+50.0%) | $828.00 K(+45.0%) |
| Sep 2005 | - | $571.00 K(+54.7%) |
| Jun 2005 | - | $369.00 K(-37.8%) |
| Mar 2005 | - | $593.00 K(+7.4%) |
| Dec 2004 | $552.00 K(+114.8%) | $552.00 K(+139.0%) |
| Sep 2004 | - | $231.00 K(0.0%) |
| Jun 2004 | - | $231.00 K(-34.7%) |
| Mar 2004 | - | $354.00 K(+37.7%) |
| Dec 2003 | $257.00 K(-72.1%) | $257.00 K(+6.6%) |
| Sep 2003 | - | $241.00 K(-16.6%) |
| Jun 2003 | - | $289.00 K(-0.3%) |
| Mar 2003 | - | $290.00 K(-68.5%) |
| Dec 2002 | $922.00 K(+18.1%) | $922.00 K(+36.2%) |
| Sep 2002 | - | $677.00 K(-13.3%) |
| Dec 2001 | $781.00 K(+21.5%) | $781.00 K(+21.5%) |
| Dec 2000 | $643.00 K(+19.5%) | $643.00 K(+19.5%) |
| Dec 1999 | $538.00 K(+35.5%) | $538.00 K(+35.5%) |
| Dec 1998 | $397.00 K(-0.8%) | $397.00 K(-0.8%) |
| Mar 1998 | - | $400.00 K(0.0%) |
| Dec 1997 | $400.00 K(0.0%) | $400.00 K(0.0%) |
| Dec 1996 | $400.00 K | $400.00 K(+100.0%) |
| Mar 1996 | - | $200.00 K |
FAQ
- What is Avadel Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual short term debt year-on-year change?
- What is Avadel Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly short term debt year-on-year change?
What is Avadel Pharmaceuticals annual short term debt?
The current annual short term debt of AVDL is $934.00 K
What is the all time high annual short term debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual short term debt is $38.63 M
What is Avadel Pharmaceuticals annual short term debt year-on-year change?
Over the past year, AVDL annual short term debt has changed by -$37.69 M (-97.58%)
What is Avadel Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of AVDL is $725.00 K
What is the all time high quarterly short term debt for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly short term debt is $44.63 M
What is Avadel Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, AVDL quarterly short term debt has changed by -$209.00 K (-22.38%)